» Articles » PMID: 1331525

Evidence That a Sequence Similar to TAR is Important for Induction of the JC Virus Late Promoter by Human Immunodeficiency Virus Type 1 Tat

Overview
Journal J Virol
Date 1992 Dec 1
PMID 1331525
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

A specific RNA sequence located in the leader of all human immunodeficiency virus type 1 (HIV-1) mRNAs termed the transactivation response element, or TAR, is a primary target for induction of HIV-1 long terminal repeat activity by the HIV-1-derived trans-regulatory protein, Tat. Human neurotropic virus, JC virus (JCV), a causative agent of the degenerative demyelinating disease progressive multifocal leukoencephalopathy, contains sequences in the 5' end of the late RNA species with an extensive homology to HIV-1 TAR. In this study, we examined the possible role of the JCV-derived TAR-homologous sequence in Tat-mediated activation of the JCV late promoter (Tada et al., Proc. Natl. Acad. Sci. USA 87:3479-3483, 1990). Results from site-directed mutagenesis revealed that critical G residues required for the function of HIV-1 TAR that are conserved in the JCV TAR homolog play an important role in Tat activation of the JCV promoter. In addition, in vivo competition studies suggest that shared regulatory components mediate Tat activation of the JCV late and HIV-1 long terminal repeat promoters. Furthermore, we showed that the JCV-derived TAR sequence behaves in the same way as HIV-1 TAR in response to two distinct Tat mutants, one of which that has no ability to bind to HIV-1 TAR and another that lacks transcriptional activity on a responsive promoter. These results suggest that the TAR homolog of the JCV late promoter is responsive to HIV-1 Tat induction and thus may participate in the overall activation of the JCV late promoter mediated by this transactivation.

Citing Articles

Bioinformatics Insights on Viral Gene Expression Transactivation: From HIV-1 to SARS-CoV-2.

Patarca R, Haseltine W Int J Mol Sci. 2024; 25(6).

PMID: 38542351 PMC: 10970485. DOI: 10.3390/ijms25063378.


JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis.

Ciardi M, Zingaropoli M, Iannetta M, Prezioso C, Perri V, Pasculli P Virol J. 2020; 17(1):23.

PMID: 32046748 PMC: 7014659. DOI: 10.1186/s12985-020-1295-5.


Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).

Khalili A, Craigie M, Donadoni M, Sariyer I J Neuroimmune Pharmacol. 2019; 14(4):649-660.

PMID: 31452013 PMC: 6898772. DOI: 10.1007/s11481-019-09877-8.


Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.

Rahimian P, He J J Neurovirol. 2016; 22(6):774-788.

PMID: 27173397 PMC: 5690550. DOI: 10.1007/s13365-016-0451-6.


Human polyomavirus reactivation: disease pathogenesis and treatment approaches.

De Gascun C, Carr M Clin Dev Immunol. 2013; 2013:373579.

PMID: 23737811 PMC: 3659475. DOI: 10.1155/2013/373579.


References
1.
Berger J, Kaszovitz B, Post M, Dickinson G . Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med. 1987; 107(1):78-87. DOI: 10.7326/0003-4819-107-1-78. View

2.
Price R, Brew B, Sidtis J, Rosenblum M, Scheck A, Cleary P . The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988; 239(4840):586-92. DOI: 10.1126/science.3277272. View

3.
PADGETT B, Walker D, ZURHEIN G, Eckroade R, DESSEL B . Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet. 1971; 1(7712):1257-60. DOI: 10.1016/s0140-6736(71)91777-6. View

4.
PADGETT B, Walker D . Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis. 1973; 127(4):467-70. DOI: 10.1093/infdis/127.4.467. View

5.
Graham F, Van Der Eb A . A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973; 52(2):456-67. DOI: 10.1016/0042-6822(73)90341-3. View